HSBC restated its 'hold' rating on CVS Health, while Manufacturers Life Insurance Company increased its stake in the company's shares.
1 report, 1 independent
Updated Sep 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
HSBC restated its 'hold' rating on CVS Health, while Manufacturers Life Insurance Company increased its stake in the company's shares.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
HSBC
British multinational bank
-
CVS Health
company
-
Manufacturers Life Insurance Company
business
Related events
- UBS upgraded CVS Health stock to a Buy rating, noting that CVS operates through its Aetna subsidiary.
- HSBC reaffirmed a hold rating on Lam Research on August 30, 2026.
- Medicare Advantage market performance is being driven by improved quality scores following the annual reset of Star Ratings.
- CLSA issued an Underperform rating for Marico due to valuation concerns, while HSBC maintained a Buy rating.